CN113876639A - A facial cream composition containing liposome for improving skin elasticity and its preparation method - Google Patents

A facial cream composition containing liposome for improving skin elasticity and its preparation method Download PDF

Info

Publication number
CN113876639A
CN113876639A CN202111338481.3A CN202111338481A CN113876639A CN 113876639 A CN113876639 A CN 113876639A CN 202111338481 A CN202111338481 A CN 202111338481A CN 113876639 A CN113876639 A CN 113876639A
Authority
CN
China
Prior art keywords
parts
skin elasticity
improving
liposome
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202111338481.3A
Other languages
Chinese (zh)
Other versions
CN113876639B (en
Inventor
杨帆
周紫燕
李沫
郭苗
周正
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hubei Maishite Biotechnology Co Ltd
Original Assignee
Hubei Maishite Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hubei Maishite Biotechnology Co Ltd filed Critical Hubei Maishite Biotechnology Co Ltd
Priority to CN202111338481.3A priority Critical patent/CN113876639B/en
Publication of CN113876639A publication Critical patent/CN113876639A/en
Application granted granted Critical
Publication of CN113876639B publication Critical patent/CN113876639B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706Algae
    • A61K8/9711Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706Algae
    • A61K8/9722Chlorophycota or Chlorophyta [green algae], e.g. Chlorella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/84Products or compounds obtained by lyophilisation, freeze-drying
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)

Abstract

The invention discloses a cream composition containing liposome for improving skin elasticity and a preparation method thereof. The face cream comprises: 0.1-16 parts of liposome for improving skin elasticity, 0.1-28 parts of emollient, 0.12-14.5 parts of emulsifier, 0.15-10.5 parts of filler, 0.24-22.4 parts of thickener, 0.01-5 parts of preservative, 0.02-3 parts of EDTA-2NA, 0.015-0.65 parts of pH regulator, 0.02-0.5 parts of daily essence and the balance of deionized water. The main components of the skin elasticity improving liposome comprise: fucus alveolii extract, palmitoyl tripeptide-5/Dunaliella salina/sodium hyaluronate/provitamin B5 complex, and nidulanic acid. The cream composition containing the liposome for improving the skin elasticity can enhance the skin elasticity and softness by compounding the components at the same time, and the liposome is used as a delivery carrier of the functional components, so that the stability of the functional components can be maintained, the transdermal efficiency of the functional components can be enhanced, and the capability of the liposome for improving the skin elasticity is increased.

Description

A facial cream composition containing liposome for improving skin elasticity and its preparation method
Technical Field
The invention relates to a skin care product and a preparation method thereof, belongs to the technical field of daily chemicals, and particularly relates to a cream composition containing liposome for improving skin elasticity and a preparation method thereof.
Background
With the increase of age, the collagen and the elastin in the facial skin of the people can be gradually reduced to cause facial relaxation, the skin loses elasticity, and the problems of facial support structure collapse, skin relaxation, wrinkles and the like are brought along.
The two main substances influencing the elasticity of the skin are collagen and elastin in the dermis, and the collagen fiber and the elastic fiber formed by the two substances are interwoven with each other to form an elastic reticular supporting structure in the skin, so that the skin is full and elastic. When aging occurs, the collagen fibers and the elastic fibers are broken and oxidized, the net structure is damaged, and then the skin loses elasticity and becomes loose and shriveled.
Meanwhile, when the skin is in a water-deficient state for a long time, the elasticity of epidermal cells can be lost; long-term irradiation of ultraviolet rays destroys collagen fibers and elastic fibers, and causes the skin to be flaccid, aged, wrinkled, and the like. Finally, bad daily work and rest are also one of the reasons for skin looseness, and when the people are in short sleep for a long time, fatigue and smoking are caused, cell repair capacity and metabolism capacity are weakened, so that collagen and elastin of the skin are lost.
To solve the problem of the impaired skin elasticity caused by these complex factors, scientific allocation of some effective components is required. In addition, since proteins supporting the skin are mainly located in the dermis layer of the skin, how to effectively deliver the efficacy ingredients into the skin local is also a problem to be solved in the industry.
Disclosure of Invention
The invention aims to provide a cream composition containing skin elasticity improving liposome, which can promote the synthesis of skin collagen and improve the skin elasticity and is greatly favored by consumers.
Another object of the present invention is to provide a method for preparing a cream composition containing liposomes for improving skin elasticity.
In order to achieve the purpose, the invention adopts the following technical scheme:
a cream composition containing skin elasticity improving liposome comprises the following components in parts by weight:
0.1-16 parts of liposome for improving skin elasticity;
84-99.9 parts of cosmetic auxiliary material matrix.
Further, the skin elasticity improving liposome comprises the following main components in parts by weight: 0.1-6.3 parts of fucus extract, 0.1-4.4 parts of palmitoyl tripeptide-5/dunaliella salina/sodium hyaluronate/provitamin B5 complex, and 0.1-5.5 parts of cubilose acid.
Further, the cosmetic auxiliary material matrix consists of the following components:
0.1-28 parts of an emollient;
0.12-14.5 parts of emulsifier;
0.15-10.5 parts of a filler;
0.24-22.4 parts of thickening agent;
0.01-5 parts of preservative;
0.02-3 parts of EDTA-2 NA;
0.015-0.65 parts of pH regulator;
0.02-0.5 parts of daily essence;
the balance being deionized water.
Preferably, the cream composition containing the skin elasticity improving liposome is characterized by comprising the following components in parts by weight:
0.5-8 parts of liposome for improving skin elasticity, which mainly comprises the following components: 0.1-2 parts of fucus extract, 0.2-4 parts of palmitoyl tripeptide-5/dunaliella salina/sodium hyaluronate/provitamin B5 complex, and 0.1-2.4 parts of cubilose acid;
1.5-20.5 parts of an emollient;
2.2-10.2 parts of emulsifier;
0.55-8 parts of a filler;
4-20 parts of a thickening agent;
0.01-1 part of preservative;
0.02-1.5 parts of EDTA-2 NA;
0.05-0.5 part of pH regulator;
0.04-0.42 part of daily essence;
the balance being deionized water.
Preferably, the cream composition containing the skin elasticity improving liposome comprises the following components in parts by weight:
5-7 parts of liposome for improving skin elasticity;
8-15 parts of an emollient;
3-8 parts of an emulsifier;
1-4 parts of a filler;
10-15 parts of a thickening agent;
0.6-1 part of preservative;
0.5-1 part of EDTA-2 NA;
0.3-0.5 parts of pH regulator;
0.1-0.4 parts of daily essence;
the balance being deionized water.
Preferably, the liposome containing skin elasticity improving liposome comprises the following main components in mass ratio: palmitoyl tripeptide-5/dunaliella salina/sodium hyaluronate/provitamin B5 complex: 1, bird's nest acid: (0.5-2.6): (0.1-0.5). Wherein palmitoyl tripeptide-5: dunaliella salina: sodium hyaluronate: provitamin B5 complex ═ 1: (1-4): (1-4): (1-2.5).
Preferably, the method for preparing the liposome containing skin elasticity improving agent comprises the following steps:
1) weighing a certain amount of fucus rudis extract, palmitoyl tripeptide-5/dunaliella salina/sodium hyaluronate/provitamin B5 complex, and cubilose acid in phosphate buffer solution, and dissolving with ultrasound;
2) weighing a certain amount of phospholipid, dissolving cholesterol in a proper amount of diethyl ether, pouring the solution obtained in the step 1) into a diethyl ether solution of the phospholipid and the cholesterol, homogenizing at a high speed for 3-10 minutes, and removing the diethyl ether at 30 ℃;
3) adding a certain amount of mannitol, carrying out ultrasonic emulsification, filtering with a 0.22-micron filter membrane, cooling the filtrate to-20 ℃ at the speed of 1-3 ℃/min, and carrying out freeze drying for 24-48 h to obtain the liposome for improving the skin elasticity.
Preferably, in the method for preparing the liposome containing the skin elasticity improving agent, the phospholipid comprises: natural phospholipids, such as soybean phospholipid, lecithin, cephalin; synthetic phospholipids such as dipalmitoylphosphatidylcholine, dipalmitoylphosphatidylethanolamine, distearoylphosphatidylcholine and the like. The mass ratio of the phospholipid material to the cholesterol is (1-6): 1.
specifically, the liposome prepared by the preparation method of the liposome for improving the skin elasticity has the particle size of 0.025-0.2 μm.
Preferably, the cream composition containing skin elasticity improving liposome, the emollient is selected from one or more of squalane, ethylhexyl isononanoate, isohexadecane, cetyl ethyl hexanoate, tocopherol acetate, polydimethylsiloxane, hexyldecanol, trehalose, octyldodecanol lauroyl glutamate, phytosterol, xylitol, hydrogenated polyisobutene, jojoba oil, polydecene, cetostearyl glucoside and behenyl alcohol.
The emulsifier is one or more selected from behenyl alcohol polyether-25, PEG-100 stearate, sorbitan olivetoleate, polysorbate 20, polysorbate-80, isocetyl stearyl alcohol polyether-20, cetearyl alcohol polyether-30, arachidyl alcohol, oleyl alcohol polyether-2, and glyceryl stearate;
the filler is selected from one or more of titanium dioxide, mica powder, talcum powder and silica;
the thickening agent is selected from one or more of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, carbomer, agar, pectin, hyaluronic acid, xanthan gum and alginic acid;
the preservative is selected from one or more of phenoxyethanol, p-hydroxybenzoate, 1, 2-pentanediol, sodium benzoate, methylparaben and sorbic acid;
the pH regulator is selected from one or two of lactic acid and arginine.
Preferably, the method for preparing the cream composition containing the liposome for improving skin elasticity comprises the following steps:
1) wetting and completely dispersing the thickening agent in water to obtain a mixed solution;
2) adding emollient, filler, preservative and EDTA-2NA into the mixed solution in the step 1), heating to 65 ℃, and homogenizing at 2500-;
3) adding an emulsifier, a daily essence and a pH regulator into the step 2), homogenizing at 2500-.
By means of the technical scheme, the invention has the following beneficial effects:
1) the innovative functional components capable of improving the skin elasticity mainly comprise: fucus alveolii extract, palmitoyl tripeptide-5/Dunaliella salina/sodium hyaluronate/provitamin B5 complex, and nidulanic acid. The three functional components are compounded simultaneously, so that the synthesis of skin collagen and elastin can be promoted, a supporting structure in a skin dermis layer is protected, and meanwhile, moisture can be provided for the skin, so that the skin is full and elastic.
2) The preparation method of the liposome for improving the skin elasticity is a freeze-drying method, and the fucus rudis extract, the palmitoyl tripeptide-5/dunaliella salina/sodium hyaluronate/provitamin B5 compound and the bird's nest acid which are effective components are wrapped by the liposome and then used, so that the effective components can enter the skin more easily to take effect, and the utilization rate of the effective components is improved.
Drawings
FIG. 1 is a graph showing the effect of inhibiting nonenzymatic glycosylation using the liposomes of example 1;
FIG. 2 is the change in the skin elasticity R2 value after use of example 1;
FIG. 3 is the change in the skin elasticity R5 value after use of example 1;
FIG. 4 is the change in the skin elasticity R7 value after use of example 1;
FIG. 5 is the change in skin elasticity test value after the use of example 1 and comparative examples 1 to 7.
Detailed Description
The invention discloses a face cream composition containing liposome for improving skin elasticity. The facial cream comprises the following raw material components in parts by weight: 0.1-16 parts of skin elasticity improving liposome, 0.1-28 parts of emollient, 0.12-14.5 parts of emulsifier, 0.15-10.5 parts of filler, 0.24-22.4 parts of thickener, 0.01-5 parts of preservative, 0.02-3 parts of EDTA-2NA, 0.015-0.65 parts of pH regulator, 0.02-0.5 parts of daily essence and the balance of deionized water. All the raw material components are commercially available products.
The main components of the skin elasticity improving liposome comprise: fucus alveolii extract, palmitoyl tripeptide-5/Dunaliella salina/sodium hyaluronate/provitamin B5 complex, and nidulanic acid. The cream composition containing the liposome for improving the skin elasticity can enhance the skin elasticity and softness by compounding the components at the same time, wherein the fucus extract at the edge of the teeth can provide certain nutrition for the skin and promote the synthesis of collagen; the palmitoyl tripeptide-5/dunaliella salina/sodium hyaluronate/provitamin B5 compound can supplement skin moisture and hyaluronic acid to increase skin plumpness; the cubilose acid can effectively remove excessive free radicals in the skin so as to protect collagen and elastin in the dermis layer of the skin.
In addition, the liposome is used as a delivery carrier of the functional components, so that the stability of the functional components can be maintained, the transdermal efficiency of the functional components can be enhanced, and the capability of the composition for improving the skin elasticity is increased.
The invention discloses a face cream composition containing skin elasticity improving liposome. The cream composition mainly comprises the following functional components for improving the skin elasticity: fucus serratus extract, palmitoyl tripeptide-5/Dunaliella salina/sodium hyaluronate/provitamin B5 complex, and nidulanic acid, which have the effects of promoting skin collagen synthesis and improving skin elasticity. Through the preferable combination and efficacy test, the most preferable composition proportion is found to obtain the efficacies of synergistically enhancing, beautifying and firming the face and repairing the skin.
(ii) Fucus serratus extract
Fucus serratus is distributed in the North Atlantic ocean, growing from the semi-tidal level to low water levels, and is a well-known algae available to humans. The Fucus serratus extract is rich in various essential amino acids, and can be used in cosmetics for providing nutrition to skin. The Fucus serratus extract can maintain skin health, participate in collagen synthesis, promote cell metabolism, and make skin compact and elastic.
(II) palmitoyl tripeptide-5/Dunaliella salina/sodium hyaluronate/provitamin B5 complex
The hyaluronic acid of the dermal layer acts as an outer frame for structural proteins (e.g., collagen, elastin) and skin cells. The reduction of hyaluronic acid in the dermis results in loss of turgor and laxity of the skin, as well as reduced skin hydration. The selected effect compound can effectively supplement hyaluronic acid for skin, repair cells, smoothen skin, promote skin moisture retention, and achieve the effects of remarkably removing wrinkles and instantly making skin soft and elastic.
Wherein, palmitoyl tripeptide-5: dunaliella salina: sodium hyaluronate: provitamin B5 complex ═ 1: (1-4): (1-4): (1-2.5).
③ bird's nest acid
The bird's nest acid is widely existed in animal tissues, and is also contained in a plurality of foods, can participate in various skin cell physiological functions, improves the skin of people, and is favored by a plurality of skin care products nowadays. The cubilose acid can promote the synthesis of structural protein in a dermis layer, can effectively inhibit non-enzymatic glycosylation reaction, effectively protects the supporting structures in the dermis layer of the skin, namely collagen and elastin, reduces the elasticity of the skin, and enables the skin to be compact and smooth.
Examples 1 to 3
A facial cream composition containing skin elasticity improving liposome comprises the following raw material components in proportion as shown in the following table 1.
TABLE 1 raw material component ratios (unit: parts by mass) of examples 1 to 3
Figure BDA0003351431200000061
Figure BDA0003351431200000071
The process for preparing the cream containing the liposome for improving skin elasticity of example 1 includes the following steps:
1) preparing the skin-elasticity-improving liposome a: weighing 750mg of fucus rudis extract, 562mg of palmitoyl tripeptide-5/dunaliella salina/sodium hyaluronate/provitamin B5 compound and 375mg of cubilose acid in 20mL of phosphate buffer solution, and dissolving by ultrasonic; weighing 2500mg of phospholipid and 500mg of cholesterol, dissolving in 20mL of diethyl ether, pouring the solution in the phosphoric acid buffer solution dissolved with the functional components into the diethyl ether solution of the phospholipid, homogenizing at high speed for 5 minutes, and removing the diethyl ether at 30 ℃; adding 2% mannitol, ultrasonic emulsifying, filtering with 0.22 μm filter membrane, and freeze drying the filtrate at 3 deg.C/min to-20 deg.C for 40h to obtain liposome with skin elasticity improving effect, wherein the particle diameter of liposome is 0.13 + -0.03 μm.
2) Wetting and completely dispersing the thickening agent in water to obtain a mixed solution;
3) adding the emollient, the filler, the preservative and the EDTA-2NA into the mixed solution obtained in the step 2), heating to 65 ℃, and homogenizing at 3200r/min for 6 minutes to completely disperse the mixed solution;
4) adding an emulsifier, a daily essence and a pH regulator into the step 3), homogenizing at 3200r/min for 6 minutes to completely emulsify the mixture, and adding the liposome a while stirring and cooling to obtain the cream composition containing the skin elasticity improving liposome.
The preparation process of the cream containing the liposome for improving skin elasticity of the above example 2 includes the following steps:
1) preparing the skin elasticity improving liposome b: weighing 150mg of fucus rudis extract, 112mg of palmitoyl tripeptide-5/dunaliella salina/sodium hyaluronate/provitamin B5 complex and 75mg of cubilose acid in 10mL of phosphate buffer solution, and dissolving by ultrasonic; weighing 500mg of phospholipid and 250mg of cholesterol, dissolving in 10mL of diethyl ether, pouring the solution in the phosphoric acid buffer solution dissolved with the functional components into the diethyl ether solution of the phospholipid, homogenizing at high speed for 3 minutes, and removing the diethyl ether at 30 ℃; adding 1% mannitol, ultrasonic emulsifying, filtering with 0.22 μm filter membrane, and freeze drying the filtrate at 1 deg.C/min to-20 deg.C for 24 hr to obtain liposome with skin elasticity improving effect, wherein the liposome particle diameter is 0.15 + -0.04 μm.
2) Wetting and completely dispersing the thickening agent in water to obtain a mixed solution;
3) adding the emollient, the filler, the preservative and the EDTA-2NA into the mixed solution obtained in the step 2), heating to 65 ℃, and homogenizing at 3000r/min for 3 minutes to completely disperse the mixed solution;
4) adding an emulsifier, a daily essence and a pH regulator into the step 3), homogenizing at 3000r/min for 3 minutes to completely emulsify the mixture, and adding the liposome b while stirring and cooling to obtain the cream composition containing the skin elasticity improving liposome.
The process for preparing the cream containing the liposome for improving skin elasticity of the above example 3 includes the following steps:
1) preparing the skin-elasticity-improving liposome c: weighing 730mg of fucus rudis extract, 548mg of palmitoyl tripeptide-5/dunaliella salina/sodium hyaluronate/provitamin B5 compound and 365mg of cubilose acid in 30mL of phosphate buffer solution, and ultrasonically dissolving; weighing 3000mg of phospholipid and 1000mg of cholesterol, dissolving in 30mL of diethyl ether, pouring the solution in the phosphoric acid buffer solution dissolved with the functional components into the diethyl ether solution of the phospholipid, homogenizing at high speed for 8 minutes, and removing the diethyl ether at 30 ℃; adding 3% mannitol, ultrasonic emulsifying, filtering with 0.22 μm filter membrane, and freeze drying the filtrate at 2 deg.C/min to-20 deg.C for 48h to obtain liposome with skin elasticity improving effect, wherein the liposome particle diameter is 0.11 + -0.03 μm.
2) Wetting and completely dispersing the thickening agent in water to obtain a mixed solution;
3) adding the emollient, the filler, the preservative and the EDTA-2NA into the mixed solution obtained in the step 2), heating to 65 ℃, and homogenizing at 3500r/min for 8 minutes to completely disperse the mixed solution;
4) adding an emulsifier, a daily essence and a pH regulator into the step 3), homogenizing at 3500r/min for 8 minutes to completely emulsify the mixture, and adding the liposome c while stirring and cooling to obtain the cream composition containing the skin elasticity improving liposome.
Test example for Effect verification
1. Safety test
Test samples: example 1;
the test method comprises the following steps: and (4) testing the safety by adopting a third-party detection mechanism. The selection area is not more than 50mm2And a suitable patch device having a depth of about 1mm, wherein about 0.02 to about 0.025ml (g) of the test substance is applied to the patch device in a closed patch test. Sticking the spot tester to the forearm of the subject, removing the test substance 24h later, observing skin reaction 0.5h, 24h and 48h after removal, and recording according to skin reaction grading standard in' cosmetic safety technical regulation 2015As a result, the coating composition was cured.
TABLE 2 Patch test results
Figure BDA0003351431200000091
Remarking: grading standard of skin reaction
Level 0: negative reaction;
level 1: carrying out suspicious reaction; only faint erythema;
and 2, stage: weak positive reaction (erythema reaction); erythema, infiltration, edema, and possibly papules;
and 3, level: strong positive reaction (herpes reaction); erythema, infiltration, edema, pimples, herpes; the reaction may be beyond the test area;
4, level: very strong response (fusional herpes response); erythema, severe infiltration, edema, fusional herpes, and response beyond the test area.
As can be seen from table 2 above, the cream prepared showed no irritation and passed safety.
2. Stability test
Test samples: example 1;
the test method comprises the following steps: and (5) observing the appearance color, viscosity and pH value for three months according to internal control standard.
Table 3 stability test results
Time 45 40℃ 37℃ 25 5℃ -15℃ CYCLE Illumination of light
1W
2W
3W
4W
2M
3M
As can be seen from the above table 3, the prepared cream has no significant changes in color, viscosity and pH value within three months under high and low temperature or illumination conditions, which indicates that the cream has better stability.
3. Efficacy testing of liposomes for improving skin elasticity
Test samples: the skin elasticity-improving liposome of example 1;
the test method comprises the following steps: and (3) adopting an in-vitro non-enzymatic glycosylation reaction experiment, and measuring the inhibition rate of the sample on non-enzymatic glycosylation by using a fluorescence spectrophotometer.
And (3) testing results: as shown in FIG. 1, the inhibition rate of the liposomes to non-enzymatic glycosylation gradually increased with the increase of the concentration of the liposomes, and reached 74% at the use amount of 5%. The liposome can obviously reduce non-enzymatic glycosylation reaction, reduce the damage of collagen and elastin at the local part of the skin, and has the functions of maintaining the skin supporting effect and protecting the elasticity of the skin.
4. Evaluation of skin elasticity-improving effect of cream
Test samples: example 1 (experimental group) and a base cream (control group: cream composition without liposome coating, other components content same as experimental group);
the test method comprises the following steps: the face cream is applied to the whole face after face cleaning every day, and the sunscreen product is applied to the whole face in the morning. The test was carried out in a room at 20-22 ℃ and 40-60% relative humidity, and the subjects had to be acclimated for 15 minutes in the same environment.
The results were tested at the following 4 time periods, respectively: before use of the sample (D0), after use of the sample for 14 days (D14), after use of the sample for 28 days (D28) and after use of the sample for 56 days (D56).
The detection items are as follows:
use of
Figure BDA0003351431200000111
MPA580 measures skin elasticity, with closer measurements to 1 indicating better skin elasticity. (R2 is the ratio of the amount of springback of the skin without negative pressure to the maximum amount of stretching during negative pressure; R5 is the ratio of the elastic portion of the skin recovery process during the first cycle of the skin test to the elastic portion of the skin recovery process during the application of negative pressure; R7 is the ratio of the elastic portion of the skin recovery process during the first cycle of the skin test to the maximum amount of stretching of the skin during this cycle).
And (3) testing results:
as shown in fig. 2 to 4 and tables 4 to 6, the significance of the R2, R5 and R7 values of the experimental group is greater than that of the control group, which indicates that the prepared cream can effectively improve the skin elasticity. The three components are wrapped by the liposome and then used simultaneously, so that the synthesis of skin collagen and elastin can be promoted, a supporting structure in the dermis layer of the skin is protected, and meanwhile, moisture can be provided for the skin, so that the skin is full and elastic.
TABLE 4 skin elasticity R2 values
Time D0 D14 D28 D56
Experimental group 0.569 0.593 0.635 0.686
Control group 0.556 0.558 0.574 0.587
TABLE 5 skin elasticity R5 values
Time D0 D14 D28 D56
Experimental group 0.516 0.586 0.612 0.674
Control group 0.521 0.536 0.547 0.565
TABLE 6 skin elasticity R7 values
Time D0 D14 D28 D56
Experimental group 0.366 0.391 0.426 0.512
Control group 0.310 0.346 0.323 0.378
5. Synergistic experiment of cream composition
The raw material components of the cream composition are in the proportion and content shown in the following table 7.
TABLE 7 ingredient proportion table (unit: parts by mass) of cream in comparative examples 1 to 7
Figure BDA0003351431200000121
Figure BDA0003351431200000131
The preparation process of the face cream comprises the following steps:
1) wetting and completely dispersing the thickening agent in water to obtain a mixed solution;
2) adding main functional components, an emollient, a filler, a preservative and EDTA-2NA into the mixed solution obtained in the step 1), heating to 65 ℃, and homogenizing at 3200r/min for 6 minutes to completely disperse the mixed solution;
3) adding an emulsifier, a daily essence and a pH regulator into the step 2), homogenizing at 3200r/min for 6 minutes to completely emulsify, stirring and cooling to obtain the cream composition.
The effects of example 1 and comparative examples 1 to 7 were verified (evaluation of skin elasticity improvement effect), and the experimental procedures and results were as follows:
1. the tester: 80 healthy women (25-45 years old) divided into 8 groups of 10 persons each; each group used the same formulation.
2. Use of: the face cream is applied to the whole face after face cleaning every day, and the sunscreen product is applied to the whole face in the morning. The test was carried out in a room at 20-22 ℃ and 40-60% relative humidity, and the subjects had to be acclimated for 15 minutes in the same environment. The results were tested at the following 4 time periods, respectively: before use of the sample (D0), after use of the sample for 14 days (D14), after use of the sample for 28 days (D28) and after use of the sample for 56 days (D56).
3. The detection items are as follows: use of
Figure BDA0003351431200000141
MPA580 measures skin elasticity, with closer measurements to 1 indicating better skin elasticity. (R2 is the ratio of the amount of springback of the skin without negative pressure to the maximum amount of stretching during negative pressure; R5 is the ratio of the elastic portion of the skin recovery process during the first cycle of the skin test to the elastic portion of the skin recovery process during the application of negative pressure; R7 is the ratio of the elastic portion of the skin recovery process during the first cycle of the skin test to the maximum amount of stretching of the skin during this cycle).
Δ R2 ═ R2 (measured after 8 weeks) -R2 (measured at week 0). Δ R5 ═ R5 (measured after 8 weeks) -R5 (measured at week 0). Δ R7 ═ R7 (measured after 8 weeks) -R7 (measured at week 0).
TABLE 8 test group Effect
Figure BDA0003351431200000142
As seen from the results of table 8 and fig. 5, the skin elasticity ability was improved: example 1> comparative examples 1 to 7.
The cream composition containing the liposome for improving the skin elasticity can effectively improve the skin elasticity, and has two main reasons that three functional components, namely, a fucus rudis extract, a palmitoyl tripeptide-5/dunaliella salina/sodium hyaluronate/provitamin B5 compound and bird's nest acid are compounded and selected, so that the skin cream composition can promote the synthesis of skin collagen and elastin, protect a supporting structure in a skin dermis layer, provide moisture for the skin and enable the skin to be full and elastic, wherein the fucus rudis extract can provide certain nutrition for the skin and promote the synthesis of collagen; the palmitoyl tripeptide-5/dunaliella salina/sodium hyaluronate/provitamin B5 compound can supplement skin moisture and hyaluronic acid to increase skin plumpness; the cubilose acid can effectively remove excessive free radicals in the skin so as to protect collagen and elastin in the dermis layer of the skin.
In addition, the liposome is used as a delivery carrier of the functional components, so that the stability of the functional components can be maintained, the transdermal efficiency of the functional components can be enhanced, and the capability of the liposome for improving the skin elasticity is increased.
The above description is only a preferred embodiment of the present invention, and is not intended to limit the present invention in any way, so that any simple modification, equivalent change and modification made to the above embodiment according to the technical spirit of the present invention are within the scope of the technical solution of the present invention.

Claims (10)

1. A cream composition containing liposome for improving skin elasticity is characterized by comprising the following components in parts by weight:
0.1-16 parts of liposome for improving skin elasticity;
84-99.9 parts of cosmetic auxiliary material matrix.
2. The cream composition containing skin elasticity improving liposomes according to claim 1, wherein the ratio of the main components of the skin elasticity improving liposomes is, in parts by weight: 0.1-6.3 parts of fucus extract, 0.1-4.4 parts of palmitoyl tripeptide-5/dunaliella salina/sodium hyaluronate/provitamin B5 complex, and 0.1-5.5 parts of cubilose acid.
3. The cream composition containing skin elasticity improving liposomes according to claim 1, wherein the cosmetic adjuvant base is composed of the following components in parts by weight:
0.1-28 parts of an emollient;
0.12-14.5 parts of emulsifier;
0.15-10.5 parts of a filler;
0.24-22.4 parts of thickening agent;
0.01-5 parts of preservative;
0.02-3 parts of EDTA-2 NA;
0.015-0.65 parts of pH regulator;
0.02-0.5 parts of daily essence;
the balance being deionized water.
4. The cream composition containing skin elasticity improving liposomes according to claim 1, wherein the cream composition is composed of the following components in parts by weight:
0.5-8 parts of liposome for improving skin elasticity, which mainly comprises the following components: 0.1-2 parts of fucus extract, 0.2-4 parts of palmitoyl tripeptide-5/dunaliella salina/sodium hyaluronate/provitamin B5 complex, and 0.1-2.4 parts of cubilose acid;
1.5-20.5 parts of an emollient;
2.2-10.2 parts of emulsifier;
0.55-8 parts of a filler;
4-20 parts of a thickening agent;
0.01-1 part of preservative;
0.02-1.5 parts of EDTA-2 NA;
0.05-0.5 part of pH regulator;
0.04-0.42 part of daily essence;
the balance being deionized water.
5. The cream composition containing skin elasticity enhancing liposomes according to any one of claims 1 to 4, wherein the skin elasticity enhancing liposomes are contained in the following main components in mass ratio:
fucus serratus extract: palmitoyl tripeptide-5/dunaliella salina/sodium hyaluronate/provitamin B5 complex: 1, bird's nest acid: (0.5-2.6): (0.1 to 0.5); wherein palmitoyl tripeptide-5: dunaliella salina: sodium hyaluronate: provitamin B5 complex ═ 1: (1-4): (1-4): (1-2.5).
6. The cream composition containing skin elasticity improving liposomes according to any one of claims 1 to 4, wherein the preparation method of the skin elasticity improving liposomes comprises the steps of:
1) weighing a certain amount of fucus rudis extract, palmitoyl tripeptide-5/dunaliella salina/sodium hyaluronate/provitamin B5 complex, and cubilose acid in phosphate buffer solution, and dissolving with ultrasound;
2) weighing a certain amount of phospholipid, dissolving cholesterol in a proper amount of diethyl ether, pouring the solution obtained in the step 1) into a diethyl ether solution of the phospholipid and the cholesterol, homogenizing at a high speed for 3-10 minutes, and removing the diethyl ether at 30 ℃;
3) adding a certain amount of mannitol, carrying out ultrasonic emulsification, filtering with a 0.22-micron filter membrane, cooling the filtrate to-20 ℃ at the speed of 1-3 ℃/min, and carrying out freeze drying for 24-48 h to obtain the liposome for improving the skin elasticity.
7. The cream composition comprising liposomes for improving skin elasticity of claim 6, wherein: the phospholipid comprises: natural phospholipids, such as soybean phospholipid, lecithin, cephalin; synthetic phospholipids, such as dipalmitoylphosphatidylcholine, dipalmitoylphosphatidylethanolamine, distearoylphosphatidylcholine; the mass ratio of the phospholipid to the cholesterol is (1-6): 1.
8. the cream composition comprising liposomes for improving skin elasticity of claim 6, wherein: the prepared liposome has the particle size of 0.025-0.2 μm.
9. The cream composition comprising liposomes for improving skin elasticity of claim 3, wherein:
the emollient is selected from one or more of squalane, ethylhexyl isononanoate, isohexadecane, cetyl ethylhexanoate, tocopherol acetate, polydimethylsiloxane, hexyldecanol, trehalose, octyldodecanol lauroyl glutamate, phytosterol, xylitol, hydrogenated polyisobutene, jojoba oil, polydecene, cetostearyl glucoside and behenyl alcohol;
the emulsifier is one or more selected from behenyl alcohol polyether-25, PEG-100 stearate, sorbitan olivetoleate, polysorbate 20, polysorbate-80, isocetyl stearyl alcohol polyether-20, cetearyl alcohol polyether-30, arachidyl alcohol, oleyl alcohol polyether-2, and glyceryl stearate;
the filler is selected from one or more of titanium dioxide, mica powder, talcum powder and silica;
the thickening agent is selected from one or more of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, carbomer, agar, pectin, hyaluronic acid, xanthan gum and alginic acid;
the preservative is selected from one or more of phenoxyethanol, p-hydroxybenzoate, 1, 2-pentanediol, sodium benzoate, methylparaben and sorbic acid;
the pH regulator is selected from one or two of lactic acid and arginine.
10. The method for preparing a cream composition containing liposomes for improving skin elasticity according to any one of claims 1 to 9, wherein: the method comprises the following steps:
1) wetting and completely dispersing the thickening agent in water to obtain a mixed solution;
2) adding emollient, filler, preservative and EDTA-2NA into the mixed solution in the step 1), heating to 65 ℃, and homogenizing at 2500-;
3) adding an emulsifier, a daily essence and a pH regulator into the step 2), homogenizing at 2500-.
CN202111338481.3A 2021-11-12 2021-11-12 A facial cream composition containing liposome for improving skin elasticity, and its preparation method Active CN113876639B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111338481.3A CN113876639B (en) 2021-11-12 2021-11-12 A facial cream composition containing liposome for improving skin elasticity, and its preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111338481.3A CN113876639B (en) 2021-11-12 2021-11-12 A facial cream composition containing liposome for improving skin elasticity, and its preparation method

Publications (2)

Publication Number Publication Date
CN113876639A true CN113876639A (en) 2022-01-04
CN113876639B CN113876639B (en) 2023-08-22

Family

ID=79017436

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111338481.3A Active CN113876639B (en) 2021-11-12 2021-11-12 A facial cream composition containing liposome for improving skin elasticity, and its preparation method

Country Status (1)

Country Link
CN (1) CN113876639B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114601920A (en) * 2022-03-23 2022-06-10 宁波御坊堂生物科技有限公司 Oral liposome composition for improving bone joint health and preparation method thereof
CN114748372A (en) * 2022-05-12 2022-07-15 武汉中科光谷绿色生物技术有限公司 Application of cubilose acid in preparation of preparation for inhibiting hyaluronic acid decomposition
CN114939076A (en) * 2022-05-12 2022-08-26 武汉中科光谷绿色生物技术有限公司 Sialic acid solid composition and preparation method and application thereof

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060018867A1 (en) * 2004-05-12 2006-01-26 Ichimaru Pharcos Co., Ltd Cosmetic composition and production thereof
CN105246357A (en) * 2013-03-26 2016-01-13 普瑞米尔营养公司 Methods for enhancing muscle protein synthesis following concurrent training
CN105579584A (en) * 2013-06-28 2016-05-11 埃泽瑞斯公司 Compositions for introducing RNA into cells
CN106109284A (en) * 2016-06-24 2016-11-16 杭州兰茜化妆品有限公司 A kind of facial film and preparation method thereof
CN106726668A (en) * 2016-11-19 2017-05-31 诺斯贝尔化妆品股份有限公司 A kind of many peptidoliposome raw materials used in cosmetics
CN110051570A (en) * 2019-04-23 2019-07-26 北京荣茂美联电子商务有限公司 A kind of double regeneration skin-active enzymolysis protein and its application
CN111000748A (en) * 2020-01-08 2020-04-14 上海瑾亭化妆品有限公司 Polypeptide repairing cream and preparation method thereof
US20200346049A1 (en) * 2019-05-03 2020-11-05 Ewc P&T, Llc Waxing based skincare treatment method and system
CN112263524A (en) * 2020-11-27 2021-01-26 湖北省麦诗特生物科技有限公司 Cosmetic composition with multiple skin care effects and preparation method thereof
CN112842960A (en) * 2021-02-03 2021-05-28 北京健讯医药科技有限公司 Cosmetic composition with ultraviolet resistance, whitening and aging resistance
CN113925820A (en) * 2021-11-26 2022-01-14 刘天康 Skin-whitening, freckle-removing and skin-protecting composition and preparation method thereof

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060018867A1 (en) * 2004-05-12 2006-01-26 Ichimaru Pharcos Co., Ltd Cosmetic composition and production thereof
CN105246357A (en) * 2013-03-26 2016-01-13 普瑞米尔营养公司 Methods for enhancing muscle protein synthesis following concurrent training
CN105579584A (en) * 2013-06-28 2016-05-11 埃泽瑞斯公司 Compositions for introducing RNA into cells
CN106109284A (en) * 2016-06-24 2016-11-16 杭州兰茜化妆品有限公司 A kind of facial film and preparation method thereof
CN106726668A (en) * 2016-11-19 2017-05-31 诺斯贝尔化妆品股份有限公司 A kind of many peptidoliposome raw materials used in cosmetics
CN110051570A (en) * 2019-04-23 2019-07-26 北京荣茂美联电子商务有限公司 A kind of double regeneration skin-active enzymolysis protein and its application
US20200346049A1 (en) * 2019-05-03 2020-11-05 Ewc P&T, Llc Waxing based skincare treatment method and system
CN111000748A (en) * 2020-01-08 2020-04-14 上海瑾亭化妆品有限公司 Polypeptide repairing cream and preparation method thereof
CN112263524A (en) * 2020-11-27 2021-01-26 湖北省麦诗特生物科技有限公司 Cosmetic composition with multiple skin care effects and preparation method thereof
CN112842960A (en) * 2021-02-03 2021-05-28 北京健讯医药科技有限公司 Cosmetic composition with ultraviolet resistance, whitening and aging resistance
CN113925820A (en) * 2021-11-26 2022-01-14 刘天康 Skin-whitening, freckle-removing and skin-protecting composition and preparation method thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LA CELLER: "la celler透明质酸滋养面霜", Retrieved from the Internet <URL:国产非特殊用途化妆品备案信息服务平台> *
NEIL: "cosmetic dermatology of the aging face", 《DERMATOLOGY》, pages 3 - 12 *
冼小敏: "燕窝蛋白质在模拟胃肠环境中的降解研究", pages 1760 - 1763 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114601920A (en) * 2022-03-23 2022-06-10 宁波御坊堂生物科技有限公司 Oral liposome composition for improving bone joint health and preparation method thereof
CN114748372A (en) * 2022-05-12 2022-07-15 武汉中科光谷绿色生物技术有限公司 Application of cubilose acid in preparation of preparation for inhibiting hyaluronic acid decomposition
CN114939076A (en) * 2022-05-12 2022-08-26 武汉中科光谷绿色生物技术有限公司 Sialic acid solid composition and preparation method and application thereof
CN114939076B (en) * 2022-05-12 2024-03-19 武汉中科光谷绿色生物技术有限公司 Sialic acid solid composition, and preparation method and application thereof
CN114748372B (en) * 2022-05-12 2024-03-19 武汉中科光谷绿色生物技术有限公司 Application of nidus Collocaliae acid in preparation of preparation for inhibiting decomposition of hyaluronic acid

Also Published As

Publication number Publication date
CN113876639B (en) 2023-08-22

Similar Documents

Publication Publication Date Title
CN113876639A (en) A facial cream composition containing liposome for improving skin elasticity and its preparation method
JP5798745B2 (en) Topically applied cosmetic or pharmaceutical composition
EP4144344A1 (en) Biomimetic and camellia extract-containing skin barrier repair composition and application thereof
CN111529417B (en) Repairing eye cream with blue light resisting effect and preparation method thereof
CN111166683A (en) Fullerene anti-aging antioxidant beauty and skin care cosmetic and preparation method thereof
CN108498382A (en) A kind of moisturizing conveys nano-composition and its preparation method and application altogether
CN114177109B (en) Composite ceramide nano composition and preparation method and application thereof
CN110013447B (en) Cream for removing striae gravidarum and preparation method thereof
CN113893203B (en) Facial cream composition containing anti-aging efficacy liposome and preparation method and application thereof
WO2023109289A1 (en) Composition containing plant fruit oil and plant seed oil, and use thereof
CN112569133A (en) Firming and anti-wrinkle essence cream and preparation method thereof
CN113995693B (en) Essence composition of liposome with anti-inflammatory effect, and preparation method and application thereof
CN111658555A (en) Nano anti-wrinkle essence cream and preparation method thereof
CN113876612B (en) A facial cream composition containing liposome for increasing skin collagen density, and its preparation method
CN113786361B (en) Eye cream composition with pouch removing effect and preparation method thereof
CN113712871B (en) Essence emulsion composition containing liposome with comedones removing effect and preparation method thereof
CN113893199B (en) A facial cream composition with effect of increasing skin thickness and its preparation method
CN110025508A (en) A kind of essence cream and preparation method thereof preventing striae of pregnancy generation
CN113730295A (en) Essence emulsion composition containing lipid nanoparticles with wrinkle-removing and tightening effects and preparation method thereof
US20120276174A1 (en) Therapeutic Treatment of Dermatologic Skin Disorders
CN113181070A (en) A skin caring cream with wrinkle removing and antiaging effects, and its preparation method
CN113876642B (en) A facial cream composition containing lipid nanoparticle with moisturizing effect and its preparation method
CN115813832B (en) Composition and eye cream for improving eye contour, and preparation method and application thereof
CN115192471B (en) Nanoemulsion gel and cosmetic composition capable of improving skin elasticity and preparation and application thereof
CN114099410B (en) Face cream composition of liposome with synergistic gain and anti-aging effects and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant